Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas W Bateman

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
JAMA Network Open|October 14, 2022
Classification of High-Grade Serous Ovarian Cancer Using Tumor Morphologic CharacteristicsKatelyn F Handley, Travis T Sims, Nicholas W Bateman, et al.
Clinical Proteomics|January 23, 2024
Mapping three-dimensional intratumor proteomic heterogeneity in uterine serous carcinoma by multiregion microsamplingAllison L Hunt, Nicholas W Bateman, Waleed Barakat, et al.
Cancers|September 9, 2022
Improving Risk Assessment for Metastatic Disease in Endometrioid Endometrial Cancer Patients Using Molecular and Clinical Features: An NRG Oncology/Gynecologic Oncology Group StudyYovanni Casablanca, Guisong Wang, Heather A Lankes, et al.
Gynecologic Oncology|April 9, 2024
Disease progression, survival, and molecular disparities in Black and White patients with endometrioid endometrial carcinoma in real-world registries and GOG/NRG oncology randomized phase III clinical trialsZachary A Kopelman, Chunqiao Tian, Jordyn Tumas, et al.
Nature Communications|October 17, 2020
Standardization and harmonization of distributed multi-center proteotype analysis supporting precision medicine studiesYue Xuan, Nicholas W Bateman, Sebastien Gallien, et al.
Nature Genetics|February 28, 2023
Multiomic analysis of homologous recombination-deficient end-stage high-grade serous ovarian cancerNikki L Burdett, Madelynne O Willis, Kathryn Alsop, et al.
NPJ Precision Oncology|March 14, 2024
Proteogenomic analysis of enriched HGSOC tumor epithelium identifies prognostic signatures and therapeutic vulnerabilitiesNicholas W Bateman, Tamara Abulez, Anthony R Soltis, et al.
NPJ Precision Oncology|May 6, 2024
Author Correction: Proteogenomic analysis of enriched HGSOC tumor epithelium identifies prognostic signatures and therapeutic vulnerabilitiesNicholas W Bateman, Tamara Abulez, Anthony R Soltis, et al.
NPJ Breast Cancer|August 18, 2025
Proteogenomic characterization of invasive breast tumors in young womenPraveen-Kumar Raj-Kumar, Jianfang Liu, Anthony R Soltis, et al.
Nature Genetics|December 1, 2022
The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancerDale W Garsed, Ahwan Pandey, Sian Fereday, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
JAMA Network Open|October 14, 2022
Classification of High-Grade Serous Ovarian Cancer Using Tumor Morphologic CharacteristicsKatelyn F Handley, Travis T Sims, Nicholas W Bateman, et al.
Clinical Proteomics|January 23, 2024
Mapping three-dimensional intratumor proteomic heterogeneity in uterine serous carcinoma by multiregion microsamplingAllison L Hunt, Nicholas W Bateman, Waleed Barakat, et al.
Cancers|September 9, 2022
Improving Risk Assessment for Metastatic Disease in Endometrioid Endometrial Cancer Patients Using Molecular and Clinical Features: An NRG Oncology/Gynecologic Oncology Group StudyYovanni Casablanca, Guisong Wang, Heather A Lankes, et al.
Gynecologic Oncology|April 9, 2024
Disease progression, survival, and molecular disparities in Black and White patients with endometrioid endometrial carcinoma in real-world registries and GOG/NRG oncology randomized phase III clinical trialsZachary A Kopelman, Chunqiao Tian, Jordyn Tumas, et al.
Nature Communications|October 17, 2020
Standardization and harmonization of distributed multi-center proteotype analysis supporting precision medicine studiesYue Xuan, Nicholas W Bateman, Sebastien Gallien, et al.
Nature Genetics|February 28, 2023
Multiomic analysis of homologous recombination-deficient end-stage high-grade serous ovarian cancerNikki L Burdett, Madelynne O Willis, Kathryn Alsop, et al.
NPJ Precision Oncology|March 14, 2024
Proteogenomic analysis of enriched HGSOC tumor epithelium identifies prognostic signatures and therapeutic vulnerabilitiesNicholas W Bateman, Tamara Abulez, Anthony R Soltis, et al.
NPJ Precision Oncology|May 6, 2024
Author Correction: Proteogenomic analysis of enriched HGSOC tumor epithelium identifies prognostic signatures and therapeutic vulnerabilitiesNicholas W Bateman, Tamara Abulez, Anthony R Soltis, et al.
NPJ Breast Cancer|August 18, 2025
Proteogenomic characterization of invasive breast tumors in young womenPraveen-Kumar Raj-Kumar, Jianfang Liu, Anthony R Soltis, et al.
Nature Genetics|December 1, 2022
The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancerDale W Garsed, Ahwan Pandey, Sian Fereday, et al.
Pageof 9